These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 21881526)

  • 1. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
    Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
    J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
    Ding HL; Guo Y; Xu MT; Li HY; Fu ZZ
    Chin Med J (Engl); 2007 Nov; 120(21):1886-9. PubMed ID: 18067760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginkgo biloba extract prevents glucose-induced accumulation of ECM in rat mesangial cells.
    Ji L; Yin XX; Wu ZM; Wang JY; Lu Q; Gao YY
    Phytother Res; 2009 Apr; 23(4):477-85. PubMed ID: 19003945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of high glucose and atorvastatin on endothelial cell matrix production.
    McGinn S; Poronnik P; Gallery ED; Pollock CA
    Diabet Med; 2004 Oct; 21(10):1102-7. PubMed ID: 15384957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effect of rosuvastatin in the regulation of metalloproteinase expression.
    Sapienza P; Borrelli V; Sterpetti AV; Dinicola S; Tartaglia E; di Marzo L
    Ann Vasc Surg; 2011 Aug; 25(6):823-9. PubMed ID: 21620672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
    Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
    Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells.
    Ho FM; Liu SH; Lin WW; Liau CS
    J Cell Biochem; 2007 May; 101(2):442-50. PubMed ID: 17203468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
    Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
    J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of overexpression of decorin on matrix metalloproteinases 2 and 9 in rat mesangial and tubular cells].
    Dong FQ; Li H; Wu F; Yao HP
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3444-7. PubMed ID: 19159581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
    Kang BY; Mehta JL
    J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
    Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin inhibits TIMP-2 and promotes myocardial angiogenesis.
    Siddiqui AJ; Gustafsson T; Sylven C; Crisby M
    Pharmacology; 2014; 93(3-4):178-84. PubMed ID: 24854110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
    Zafiriou S; Stanners SR; Saad S; Polhill TS; Poronnik P; Pollock CA
    J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.